Company Filing History:
Years Active: 2011-2013
Title: The Innovations of Hideyuki Yasuno
Introduction
Hideyuki Yasuno is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of genetics, particularly in the development of oligonucleotides for genotyping the thymidylate synthase gene. His work has implications for understanding the responsiveness of subjects to antitumor agents.
Latest Patents
Yasuno holds 2 patents related to his innovative research. His latest patents focus on oligonucleotides for genotyping the thymidylate synthase gene. These oligonucleotides allow for the identification of the number of tandem repeats in the promoter region of the thymidylate synthase gene. This identification is achieved through the hybridization of the oligonucleotide to the genomic DNA of a subject. Consequently, the genotype of the thymidylate synthase gene can be determined based on the number of tandem repeats, which is crucial for assessing a subject's responsiveness to antitumor agents.
Career Highlights
Hideyuki Yasuno is currently associated with F. Hoffmann-La Roche AG, a leading global healthcare company. His role at the company allows him to further his research and contribute to advancements in medical science.
Conclusion
Hideyuki Yasuno's work in the field of genetics, particularly with his patents on oligonucleotides, showcases his innovative spirit and dedication to improving healthcare outcomes. His contributions are vital for the ongoing research in antitumor responsiveness.